Skip to main content

1 Result(s)

within Igor Đurišić Remove this filter

and

  1. No Access

    Article

    Potential clinical relevance of uPA and PAI-1 levels in node-negative, postmenopausal breast cancer patients bearing histological grade II tumors with ER/PR expression, during an early follow-up

    We evaluated urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor-1 (PAI-1) prognostic value in postmenopausal, node-negative breast cancer patients bearing tumors with estrogen recep...

    Marko Buta, Radan Džodić, Igor Đurišić, Ivan Marković, Tijana Vujasinović… in Tumor Biology (2015)